Daniel Bouthillier
Chief Tech/Sci/R&D Officer bij DEVONIAN HEALTH GROUP INC.
Profiel
Daniel Bouthillier was the founder of Kaneq Bioscience Ltd.
(founded in 2012) where he held the title of President & Chief Executive Officer.
He is also the founder of Kaneq Pharma, Inc. Dr. Bouthillier's current jobs include Director positions at Québec Biotechnology Innovation Centre, Kanyr Pharma, Inc., and Vice President-Research at Devonian Health Group, Inc. His former jobs include Vice Chairman at Génome Québec, Inc., Executive Director-Global Facilities Management at Merck & Co., Inc. (from 2007 to 2010), and Senior Scientist & Head-Administrator at Clinical Research Institute of Montreal.
Dr. Bouthillier received a doctorate from the University of Montréal and an MBA from HEC Montréal.
Actieve functies van Daniel Bouthillier
| Bedrijven | Functie | Begin |
|---|---|---|
| DEVONIAN HEALTH GROUP INC. | Chief Tech/Sci/R&D Officer | - |
Québec Biotechnology Innovation Centre
 Québec Biotechnology Innovation Centre BiotechnologyHealth Technology Québec Biotechnology Innovation Centre operates research and development center for biotechnology. It offers infrastructure, consulting, and funding services. The company was founded in 1995 and is headquartered in Laval, Canada. | Director/Board Member | - |
| Kanyr Pharma, Inc. | Director/Board Member | - |
Eerdere bekende functies van Daniel Bouthillier
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01-08-2010 |
Clinical Research Institute of Montreal
 Clinical Research Institute of Montreal Miscellaneous Commercial ServicesCommercial Services The Clinical Research Institute of Montreal engages in clinical research. | Chief Administrative Officer | - |
Génome Québec, Inc.
 Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Director/Board Member | - |
| Kaneq Pharma, Inc. | Founder | - |
Kaneq Bioscience Ltd.
 Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | Chief Executive Officer | - |
Opleiding van Daniel Bouthillier
| University of Montréal | Doctorate Degree |
| HEC Montréal | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| DEVONIAN HEALTH GROUP INC. | Health Technology |
| Bedrijven in privébezit | 6 |
|---|---|
Génome Québec, Inc.
Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Clinical Research Institute of Montreal
Clinical Research Institute of Montreal Miscellaneous Commercial ServicesCommercial Services The Clinical Research Institute of Montreal engages in clinical research. | Commercial Services |
Québec Biotechnology Innovation Centre
Québec Biotechnology Innovation Centre BiotechnologyHealth Technology Québec Biotechnology Innovation Centre operates research and development center for biotechnology. It offers infrastructure, consulting, and funding services. The company was founded in 1995 and is headquartered in Laval, Canada. | Health Technology |
Kaneq Bioscience Ltd.
Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada. | Health Technology |
| Kanyr Pharma, Inc. | |
| Kaneq Pharma, Inc. |
